David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$327M |
| 2 |
Netflix
NFLX
|
+$275M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$219M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Merck
MRK
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$558M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$259M |
| 3 |
Meta Platforms (Facebook)
META
|
+$252M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$252M |
| 5 |
IBM
IBM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.49% |
| 2 | Technology | 7.17% |
| 3 | Consumer Discretionary | 7.02% |
| 4 | Healthcare | 6.66% |
| 5 | Communication Services | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATMI
3301
DELISTED
A T M I INC
ATMI
| $839K | ﹤0.01% |
27,772
+5,067
| +22% | +$145K |
|
3302
First Horizon
FHN
$11.6B
| $838K | ﹤0.01% |
71,938
-504,504
| -88% | -$5.64M |
|
|
NPSP
3303
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $838K | ﹤0.01% |
27,600
-100
| -0.4% | -$2.75K |
|
3304
United Bankshares
UBSI
$6.46B
| $836K | ﹤0.01% |
26,583
+1,223
| +5% | +$37.4K |
|
3305
PUT
Insperity
NSP
$1.98B
| $835K | ﹤0.01% |
+46,200
| New | +$828K |
|
|
ASMI
3306
DELISTED
ASM INTERNATL N.V
ASMI
| $835K | ﹤0.01% |
25,291
-7,117
| -22% | -$237K |
|
3307
Stryker
SYK
$126B
| $834K | ﹤0.01% |
11,103
+7,045
| +174% | +$514K |
|
3308
Thor Industries
THO
$4.05B
| $834K | ﹤0.01% |
+15,100
| New | +$834K |
|
3309
HealthStream
HSTM
$841M
| $833K | ﹤0.01% |
+25,428
| New | +$869K |
|
3310
PUT
RPM International
RPM
$13.7B
| $830K | ﹤0.01% |
20,000
-40,000
| -67% | -$1.56M |
|
|
FNSR
3311
PUT
DELISTED
Finisar Corp
FNSR
| $828K | ﹤0.01% |
34,600
+7,000
| +25% | +$160K |
|
|
USAP
3312
DELISTED
Universal Stainless & Alloy
USAP
| $827K | ﹤0.01% |
22,930
+13,885
| +154% | +$466K |
|
3313
Accuray
ARAY
$31.6M
| $826K | ﹤0.01% |
94,895
-179,836
| -65% | -$1.4M |
|
|
SMA
3314
DELISTED
SYMMETRY MEDICAL INC
SMA
| $826K | ﹤0.01% |
81,917
-9,491
| -10% | -$82.6K |
|
3315
Gladstone Investment Corp
GAIN
$653M
| $823K | ﹤0.01% |
102,114
+87,561
| +602% | +$646K |
|
|
3316
PUT
HealthStream
HSTM
$841M
| $823K | ﹤0.01% |
25,100
| – | – |
|
3317
Clean Harbors
CLH
$16.6B
| $822K | ﹤0.01% |
+13,711
| New | +$791K |
|
3318
PUT
NiSource
NI
$19.7B
| $822K | ﹤0.01% |
63,625
| – | – |
|
|
CTIC
3319
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $821K | ﹤0.01% |
42,746
-8,715
| -17% | -$159K |
|
|
WIBC
3320
DELISTED
WILSHIRE BANCORP INC
WIBC
| $821K | ﹤0.01% |
75,102
-58,761
| -44% | -$553K |
|
3321
CALL
Clearfield
CLFD
$406M
| $820K | ﹤0.01% |
+40,500
| New | +$676K |
|
|
BBOX
3322
DELISTED
Black Box Corp
BBOX
| $820K | ﹤0.01% |
27,530
-8,636
| -24% | -$241K |
|
3323
CALL
Plexus
PLXS
$6.52B
| $818K | ﹤0.01% |
+18,900
| New | +$749K |
|
|
NM
3324
CALL
DELISTED
Navios Maritime Holdings Inc.
NM
| $818K | ﹤0.01% |
+7,330
| New | +$592K |
|
|
NWY
3325
DELISTED
New York & Co Inc
NWY
| $812K | ﹤0.01% |
185,899
-3,025
| -2% | -$15.1K |
|
Similar funds
David Shaw's Q4 2013 Portfolio in Review
As of Q4 2013, David Shaw held 4,972 positions worth $73.3B, up 17% from $62.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $3.59B of net new capital in Q4 2013, opening 721 new positions and adding to 1,786 existing holdings. Its largest new stake was Allegion: 2,233,249 shares worth $98.7M.
By sector, the portfolio is most concentrated in Financials at 7.5% of assets, up from 7% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $252M trimmed.
- David Shaw's largest Q4 2013 buy was Allegion: 2,233,249 shares worth $98.7M.
- David Shaw added most to Bank of America in Q4 2013, an estimated $327M increase.
- David Shaw's biggest Q4 2013 reduction was Meta Platforms (Facebook), cutting an estimated $252M.
- David Shaw fully exited DELL INC in Q4 2013, selling an estimated $558M.
- David Shaw's ten largest holdings make up 13% of its $73.3B portfolio in Q4 2013.
- David Shaw opened 721 new positions and closed 549 in Q4 2013.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $73.3B.
Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.